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Abstract Background The aim of this study was to assess how coronary flow, oxygen supply and
energy demand affect myocardial ATP, phosphocreatine and their metabolites during
oxygen shortage and recovery.
Methods Isolated rat hearts were exposed for 20 min to either low-flow ischaemia or
hypoxaemia at the same oxygen supply, followed by return to baseline conditions
(20 min). Seventy-three hearts were divided into four groups: ischaemic or hypoxaemic,
spontaneously beating or paced to increase energy demand.
Results During O2 shortage, myocardial performance was less in ischaemic, spontaneously
beating hearts (SpIs), than in the other groups (14 6 1% of baseline vs. 25–48%).
Consequently, the tissue levels of ATP, total adenylates and phosphocreatine were main-
tained in SpIs, in contrast to marked decreases in the other groups. Upon reflow, the
recovery of performance and of myocardial ATP was 94 6 5% in SpIs (PNS vs. baseline)
compared with 64–85% (P <0·05 vs. baseline) in the other groups. The degree of recovery
was positively related to the ischaemic contents of ATP (P 0·03) and adenylates
(P 0·001), but not to that of phosphocreatine (PNS).
Conclusion The maintenance of the ATP pool under low oxygen supply conditions is
essential for good recovery. The most important factors that determine the ATP pool size are
the energy demand, which increases the formation of diffusible ATP catabolites, and the
coronary flow, which removes these catabolites, rather than the oxygen supply per se.
Keywords ATP, energy demand, hypoxia, myocardial metabolism, phosphocreatine, purine
metabolism.
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Introduction
Although the only way to recover ischaemic hearts, reflow
is often associated with damage. Only part of this damage,
however, is due to the free radicals generated concomi-
tantly with oxygen readmission [1]. The biochemical
mechanisms underlying damage are still elusive, but high-
energy phosphates are probably involved, because damage
is limited if the tissue ATP level is maintained during
ischaemia [2–4]. The role of ongoing glycolysis is contro-
versial, as it appears detrimental during no-flow ischaemia
but beneficial during low-flow ischaemia [5]. However, the
implications of glycolysis, especially in relation to ischaemic
preconditioning, are described elsewhere [6].
Assessing the effects of energy demand and coronary
flow on the metabolism of total adenine nucleotides and
purines (TANP) may help to clarify the above issue. We
have recently shown that a situation of low coronary flow,
by depressing the washout of lactate, can strongly down-
regulate myocardial performance [7,8]. In addition,
coronary flow appears crucial in determining recovery
after ischaemia as it helps to wash out diffusible TANP,
i.e. inosine, hypoxanthine, xanthine and urate, thereby
reducing tissue ATP level [9]. Although it has already
been hypothesized that residual flow increases the washout
of TANP formed during O2 shortage [10,11], the relation-
ship between reperfusion injury, tissue TANP, coronary
flow and energy demand has not yet been established.
In this work, we verify the existence of such link by
testing the hypothesis that dysfunction measured during
reflow depends on factors which depend on both the energy
demand and the residual coronary flow during ischaemia.
High energy demand enhances formation of ATP-derived
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membrane-diffusible substances, whereas high residual cor-
onary flow promotes definitive loss of these substances for
the contractile system. By comparing various experimental
conditions characterized by the same O2 supply yet different
energy demand and coronary flow levels during ischaemia,
we show that the maintenance of the ATP level during O2
shortage protects hearts. In addition, we show that both high
energy demand and high coronary flow can determine the
size of the ATP pool during the recovery phase.
Materials and methods
Heart perfusion
Ad libitum-fed male Sprague–Dawley rats (250–280 g)
were anaesthetized by i.p. heparinized sodium thiopental
(10 mg 100 gÿ1 b.w.); hearts were excised and perfused at
378C with a medium containing (in mmol Lÿ1) NaCl
(115·6), KCl (4·7) KH2PO4 (1·2), EDTA (0·5), Na2SO4
(1·2), NaHCO3 (28·5), CaCl2 (2·5), MgCl2 (1·2) and
glucose (16·6), pH 7·40 6 0·02 at PCO243 mmHg. A
roller pump (Gilson, France) delivered the medium at
preselected flows to a filter (8 mm pore size, 47 mm dia-
meter, Nuclepore Pleasanton, CA, USA), a membrane
oxygenator, flowed with gas at PO2 of either 670 or 67
mmHg, a preheater and the aortic cannula. The venous
return was collected from the pulmonary artery for
measurement of venous PO2 (YSI model 5300 Oxygen
Monitor, Yellow Springs, OH, USA) and O2 uptake (VO2).
A saline-filled balloon in the left ventricle was connected to a
pressure transducer (Harvard Apparatus model 52-9966,
Natick, MA, USA) for measurement of end-diastolic pres-
sure (EDP), left-ventricle developed pressure (LVDP) and
heart rate (HR). Hearts from the paced groups were stimu-
lated throughout at 330 minÿ1 by electrodes (Harvard,
South Natick, MA, USA: square wave stimulator, 5 ms
pulse duration, 10 V pulse amplitude) placed on the aortic
cannula and on the apex of the ventricle. To account for
different HRs in the various groups, myocardial
performance is expressed as LVDP · HR.
Experimental protocol
Hearts were stabilized for 30 min at flow 15 mL minÿ1,
PaO2 670 mmHg, O2 supply 14·1 mmol min
ÿ1. The
balloon volume was adjusted to achieve an EDP of approxi-
mately 10 mmHg and was then kept constant throughout.
Hearts were assigned to one of the following groups: SpIs
(spontaneously beating hearts exposed to low-flow ische-
mia and then reperfused at a flow rate of 15 mL minÿ1;
n 9); SpHy (spontaneously beating hearts exposed to
hypoxaemia and then reoxygenated at PaO2 670 mmHg;
n 8); PxIs (paced hearts exposed to low-flow ischaemia
and then reperfused at a flow rate of 15 mL minÿ1; n 9);
PxHy (paced hearts exposed to hypoxaemia and then
reoxygenated at PaO2670 mmHg; n 8). Recovery was
quantitated as the ratio (performance during reflow or
reoxygenation)/(performance during baseline). Low-flow
ischaemia and hypoxaemia were maintained for 20 min
either by reducing flow to 1·5 mL minÿ1 or by switching
to the low-PO2 gas. The two conditions were thus matched
for O2 supply (10% of baseline), duration (20 min) and
temperature (378C). Hearts were freeze-clamped at the end
of reflow or reoxygenation (20 min) to determine tissue
content of high-energy phosphates and their metabolites.
In parallel experiments, additional hearts were freeze-
clamped after the periods of baseline (seven spontaneously
beating and six placed), low-flow ischaemia (7/6) and
hypoxaemia (8/5).
High performance liquid chromatography
Hearts were freeze-clamped with aluminium clamps and
then cooled in liquid nitrogen; tissue was extracted with 0·5
mol Lÿ1 perchloric acid, neutralized and analysed for ATP,
ADP, AMP, adenosine, inosine-50-monophosphate, ino-
sine, hypoxanthine, xanthine, urate, creatine and phospho-
creatine (Pcr) by high-performance liquid chromatography
as previously described [12]. Using this technique, hypox-
anthine coelutes with xanthine and inosine with urate. The
level of TANPs was calculated as the sum of all the above
substances except creatine and Pcr. The diffusible sub-
stances include adenosine, inosine, hypoxanthine, xanthine
and urate.
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Figure 1 Developed and end-diastolic pressures (mmHg). The
O2 supply was reduced at t0–20 min by decreasing either
coronary flow or PO2 to 10% of baseline. The vertical bars
represent SE. Two-way ANOVA for both, P <0·0001. SpIs (B),
spontaneously beating hearts exposed to low-flow ischaemia and
reflow; SpHy (X), spontaneously beating hearts exposed to
hypoxaemia and reoxygenation; PxIs (A), paced hearts exposed
to low-flow ischaemia and reflow; PxHy (W), paced hearts
exposed to hypoxaemia and reoxygenation. *Significant
difference vs. SpIs.
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Statistics
Data are expressed as means 6 SE. To detect interactions
between the various groups and three consecutive perfu-
sion conditions (baseline, O2 shortage, and recovery), we
used to analysis of variance (ANOVA) procedures (StatView,
Abacus Concepts, Berkeley, CA, USA), depending on the
variable being tested: two-way, repeated-measures ANOVA
for variables available for each heart under the three
conditions; and factorial, six-groups ANOVA for variables
such as, for example, the myocardial metabolites content.
In both cases, if the ANOVA test was significant (P <0·05),
hearts were compared with the Bonferroni/Dunnett
multiple comparison procedure.
Results
General
Hearts did not stop contracting during O2 shortage and
recovery; thus, their performance could be monitored
continuously (Fig. 1). Figures 1 and 2 show that, although
almost complete in SpIs, functional recovery upon reflow
or reoxygenation was impaired in the other groups. Figures
3 and 4 report the tissue metabolite levels measured at the
end of the various phases. As observed for myocardial
performance, the recovery of ATP and TANP was almost
complete in SpIs, in contrast to progressive impairment in
the other groups. However, both Pcr and the sum Pcr
creatine were maintained in all the groups. Electron micro-
scopy did not reveal signs of irreversible injury in any group
(not shown).
Effects of pacing at full O2 supply (baseline)
LVDP was lower in paced than in spontaneously beating
hearts, with higher VO2 (Table 1). However, HR was higher
in paced hearts, so that LVDP · HR was the same in the
two groups. No differences were observed for EDP or most
metabolic parameters, with the exception of inosine-50-
monophosphate, which was higher, and adenosine, which
was lower in paced than in spontaneously beating hearts.
Low-flow ischaemia and reflow in spontaneously
beating hearts (SpIs)
As expected myocardial contractility decreased abruptly at
the onset of low-flow ischaemia. In addition, HR decreased
to 178 6 12 minÿ1 (P < 0·0001 with respect to baseline).
However, there were no signs of diastolic contracture, and
the level of tissue metabolites was preserved throughout the
ischaemic period. At the end of the reflow, none of the
examined parameters, including HR (264 6 15 minÿ1),
was significantly different from baseline. This indicates
near complete functional and metabolic recovery in
SpIs.
Figure 2 Performance recovery at end of reflow or reoxygena-
tion. Data are expressed as per cent of baseline values. Two-way
ANOVA, P <0·0001 and P0·08 for developed pressure · heart
rate and VO2 respectively. Same conventions as in Fig. 1.
Figure 3 Myocardial content of adenine
nucleotides and purines in spontaneously
contracting (left) and paced (right)
hearts. The bars on the top represent
IMP on a different scale range. One-way
ANOVA, P <0·0001 for all substances.
#Significant difference (P <0·05) in the
toal content of adenine nucleotides and
purines compared with spontaneously
beating hearts exposed to low-flow
ischaemia and reflow (SpIs). *Significant
difference (P <0·05) compared with
spontaneously beating hearts exposed to
low-flow ischaemia and reflow (SpIs).
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Effects of coronary flow (SpHy)
In SpHy the decrease of myocardial contractility at the
onset of O2 shortage was less pronounced than in SpIs.
Thus, the myocardial performance was higher in SpHy
than in SpIs even at the same supply of O2. In addition,
EDP was higher, indicating onset of diastolic contracture.
The levels of ATP, Pcr and TANP were lower, with higher
IMP. Upon return to baseline conditions, HR recovered
completely (261 6 17 minÿ1, PNS with respect to base-
line), but LVDP, LVDP · HR, ATP and TANP were lower
than during baseline, with higher EDP. This indicates
consistent damage in SpIs.
Effects of high energy demand (PxIs)
During low-flow ischaemia, PxIs developed significant
diastolic contracture. Although LVDP was similar to that
of SpIs the total work output (EDPLVDP) · HR was
9·9 6 0·7 in PxIs vs. 6·2 6 0·5 mmHg · 103 minÿ1 in SpIs
(P <0·01). This indicates that PxIs performed at higher
level than SpIs. At the end of the reflow, the recovery of
LVDP · HR, tissue ATP and TANP was superimposable
on that observed for SpHy.
Simultaneous effects of high energy demand and
coronary flow (PxHy)
During O2 shortage, PxHy developed a pattern super-
imposable on that of PxIs and SpHy: high EDP and
LVDP with lower ATP, TANP and Pcr. During reoxygena-
tion, the recovery of LVDP, LVDP · HR, ATP and TANP
was also similar to that observed in SpHy and PxIs.
Discussion
The design of this study allowed us to assess separately the
effects of residual coronary flow by comparing SpIs with
SpHy, and those of energy demand by comparing SpIs with
PxIs. Group PxHy assessment of the simultaneous effects
of coronary flow and energy demand. The product LVDP ·
HR is an index of myocardial function in this model
because it is not affected by pacing in normoxic hearts.
The higher VO2 in paced hearts might be due to greater O2
cost of increasing HR compared with force development.
Bioenergetics of low-flow ischaemia and
hypoxaemia
In spontaneously beating hearts, lowflow ischaemia down-
regulates myocardial performance to a much greater extent
than hypoxaemia. Identifying the factors that determine
down-regulation is beyond the aims of this study, but
presumably different degrees of lactate or H washout
secondary to different coronary flow rates are involved
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Figure 4 Myocardial content of creatine and phosphocreatine.
One-way ANOVA P < 0·0001 for all substances. Same conventions
as in Fig. 3.
Table 1 Myocardial performance and metabolism (mean 6 SE) at baseline.
Spontaneous P Paced
n 39 34
HR (minÿ1) 266 6 6 <0·0001 330 6 0
EDP (mmHg) 9·4 6 0·5 NS 9·8 6 0·3
LVDP (mmHg) 148 6 3 <0·0001 115 6 3
LVDP · HR (mmHgx 103 minÿ1) 39·4 6 1·2 NS 37·9 6 1·0
VO2 (mmol min
ÿ1) 6·68 6 0·40 0·008 7·95 6 0·20
ATP (mmol gÿ1 dry wt) 21·9 6 1·6 NS 20·9 6 0·7
IMP (mmol gÿ1 dry wt) 0·04 6 0·04 0·001 0·36 6 0·04
Adenosine (mmol gÿ1 dry wt) 0·54 6 0·15 0·01 0·15 6 0·07
TANP (mmol gÿ1 dry wt) 33·9 6 2·6 NS 32·6 6 1·1
Pcr (mmol gÿ1 dry wt) 26·4 6 2·4 NS 27·7 6 2·5
The differences between the two groups were tested by Student’s t-test for unpaired samples.
For metabolites, n7 and 6 for spontaneous and paced hearts respectively. IMP, inosine-50
monophosphate.
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[7]. By reducing contractility and by maintaining the levels
of ATP, TANP and Pcr near preischaemic values, SpIs
achieve a favourable perfusion–contraction matching
between energy supply and demand, which is compatible
with short-term hibernation [13]. This allows greater
recovery in these hearts. Both high flow and pacing
unmatch the perfusion–contraction matching by increas-
ing energy demand. This results in a fall in high-energy
phosphates, increased ATP catabolism, increased washout
of diffusible substances and impaired recovery following
return to baseline conditions.
The fact that oxidative metabolism (VO2) during O2
shortage was the same in all groups stresses the increasing
importance of glycolytic ATP, which meets the energy
requirements under O2 shortage conditions. Presumably,
endogenous glycogen is the most important fuel source to
sustain the higher contractility in SpHy [8]. We did not
measure lactate production in PxIs and PxHy but the data
reported in [7] show that pacing increases the rate of
glycolysis in ischaemic hearts only, whereas this rate is
unaffected in hypoxaemic hearts. Perhaps, in PxIs and
SpHy, the glycolytic rate is already near maximum. In
fact, the values of lactate production during hypoxaemia
(9·2–10·8 mmol minÿ1 gÿ1 wet wt or 71–83 mmol minÿ1
gÿ1 dry wt) are close to the values of 10–14 mmol minÿ1 gÿ1
wet wt [14] and 60–70mmol minÿ1 gÿ1 dry wt [15] reported
for contracting anoxic isolated rate hearts.
Although its role in heart muscle is not yet fully clear,
IMP is considered a good index of metabolic derangement
during O2 shortage. In addition, the lowest IMP level
during O2 shortage (SpIs) was associated with the greatest
down-regulation of myocardial performance during ischae-
mia. Photoaffinity labelling studies in rat have revealed the
presence of IMP binding sites on the myosin complex [16].
In addition, IMP inhibits actin-activated Mg2-myosin
ATPase activity [17]. Finally, loss of performance in rat
medial gastrocnemius muscle is associated with increases in
muscle IMP content [18]. In the normoxic heart, AMP is
mainly deaminated to IMP because AMP deaminase activ-
ity is much larger than that of 50-nucleotidase. However,
during O2 shortage, increases in Pi inhibit AMP deaminase,
resulting in the release of adenosine [19,20].
Diffusible substances and myocardial dysfunction
Loss of diffusible substances is crucial to determine
recovery in this model. In oxygenated tissues, ATP dephos-
phorylation is tightly coupled with ADP phosphorylation;
thus, the loss of diffusible ATP catabolites is slow and
compensated by purine salvage and de novo synthesis [21].
When energy supply is low relative to demand, ATP break-
down may exceed synthesis, thereby increasing the amount
of diffusible catabolites. This does not occur in SpIs
because of perfusion–contraction matching, but TANP
progressively decreases in the other groups. Thus, both
the excessive ATP breakdown with respect to synthesis and
the high coronary flow finally lead to loss of diffusible
substances. TANP loss is not accompanied by parallel
changes in Pcr creatine because both Pcr and creatine
do not leak across intact membranes [22]. Therefore,
TANP depletion is a metabolic phenomenon that occurs
even in the absence of irreversible membrane damage.
This is confirmed by lack of ultrastructural alterations
and of enzyme release. The preservation of the ATP pool
during O2 shortage is a major contributor to heart
protection (Fig. 5), in agreement with previous studies
[2,3,23].
Figure 5 Relationship between per cent LVDP · HR recovery
and the myocardial contents of ATP, sum of adenine nucleotides
and purines or phosphocreatine, measured at the end of O2
shortage. Best-fit lines are: ATP, y31·213·12x, r20·92,
P0·05; for TANP, yÿ23·13·44x, r20·98, P0·005; for
phosphocreatine, r20·50, PNS. SpIs, spontaneously beating
hearts exposed to low-flow ischaemia and reflow; SpHy, sponta-
neously beating hearts exposed to hypoxaemia and reoxygenation;
PxIs, paced hearts exposed to low-flow ischaemia and reflow;
PxHy, paced hearts exposed to hypoxaemia and reoxygenation.
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Implications of this study
A relationship between functional recovery and mainte-
nance of diffusible substances has emerged. In this model,
low coronary flow and low energy demand maintain diffu-
sible substances homeostasis. In contrast, the O2 supply per
se does not appear to be as critical. High coronary flow and
high energy demand increase the amount of diffusible
substances formed from ATP catabolism, result in low
tissue ATP levels and are associated with poor recovery.
The extent of recovery critically depends on both energy
demand and flow during ischaemia, and not on the severity
of O2 shortage.
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